The eyes don't see what the mind doesn't know: discovering monoclonal gammopathy of thrombotic or thrombocytopenic significance

Anjali Srikanth Mannava; Raja Narendra Divakar Addanki

doi:10.18203/2320-6012.ijrms20232823

Authors

Anjali Srikanth Mannava Department of Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Raja Narendra Divakar Addanki Department of Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20232823

Keywords:

Monoclonal gammopathy, Thombosis, MGTS

Abstract

A new scientific advancement in the field of medicine has been made thanks to the collaboration between the university of Michigan health and mayo clinic. A previously undiscovered illness has been named Monoclonal Gammopathy of Thrombotic/Thrombocytopenic Significance (MGTS) as a result of thorough investigation and the convergence of facts. The ramifications of this discovery for medical professionals are considerable, and they may lead to a radical change in how we approach patient care, diagnosis, and treatment.

Metrics

Metrics Loading ...

References

Kanack AJ, Schaefer JK, Sridharan M, Splinter NP, Kohlhagen MC, Singh B et al. Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood. 2023;141(14):1772-6.

Lach B, Rippstein P, Atack D, Afar DE, Gregor A. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta neuropathologica. 1993;85(3):298-307.

Chaudhry HM, Mauermann ML, Rajkumar SV. Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management. Mayo Clinic Proceedings. 2017;92(5):838-50.

Cesarman-Maus G, Braggio E, Fonseca R. Thrombosis in multiple myeloma (MM). Hematology (Amsterdam, Netherlands). 2012;17(1):S177-80.